COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir – CIDRAP Original study: Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial – JAMA Network Open   Commentary on Twitter (thread – Click for more) 1/ No benefit from Hydroxychloroquine or Lopinavir-Ritonavir on […]

The post RCT: COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir appeared first on Links Medicus.